29 April 2021
Case Study: Theradaptive and Regenerative Medicine
HOW WORKING WITH GENEVA SET THE FOUNDATION FOR TECHNOLOGY TRANSFER AND CLINICAL SUCCESS.
Geneva has worked with Theradaptive, Inc., a privately-held biotechnology company focused on regenerative medicine technology, on getting their therapeutic platform into the clinic since 2017. The company’s founder is a 20-year Army veteran and MIT alumnus retired LTC Luis Alvarez, PhD. LTC Alvarez developed the platform technology during active duty in the Army.
In this Case Study, you will find:
- The role of tech transfer in the military
- Theradaptive’s impact on healthcare
- Geneva’s tech transfer capabilities
- Map of military treatment facilities Geneva is working with to advance regenerative medicine
Geneva is proud to have over 25 years of experience in delivering full-spectrum scientific, technical, and program management expertise in the areas of federal contracts, federal grants, and industry-sponsored clinical trials.
